415 related articles for article (PubMed ID: 32834893)
1. Does hereditary angioedema make COVID-19 worse?
Xu Y; Liu S; Zhang Y; Zhi Y
World Allergy Organ J; 2020 Sep; 13(9):100454. PubMed ID: 32834893
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
4. C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
Hausburg MA; Williams JS; Banton KL; Mains CW; Roshon M; Bar-Or D
Clin Immunol Commun; 2022 Dec; 2():83-90. PubMed ID: 38013973
[TBL] [Abstract][Full Text] [Related]
5. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
Veronez CL; Christiansen SC; Smith TD; Riedl MA; Zuraw BL
Allergy Asthma Proc; 2021 Nov; 42(6):506-514. PubMed ID: 34871158
[No Abstract] [Full Text] [Related]
7. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
8. Effect of COVID-19 on hereditary angioedema activity and quality of life.
Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
[No Abstract] [Full Text] [Related]
9. The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
Hansen CB; Csuka D; Munthe-Fog L; Varga L; Farkas H; Hansen KM; Koch C; Skjødt K; Garred P; Skjoedt MO
J Immunol; 2015 Oct; 195(8):3596-604. PubMed ID: 26371246
[TBL] [Abstract][Full Text] [Related]
10. HAE patient self-sampling for biomarker establishment.
Förster TM; Magerl M; Maurer M; Zülbahar S; Zielke S; Inhaber N; Crocetta D; Rolfs A; Skrahina V
Orphanet J Rare Dis; 2021 Sep; 16(1):399. PubMed ID: 34583739
[TBL] [Abstract][Full Text] [Related]
11. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
13. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
Marceau F; Rivard GE; Gauthier JM; Binkley KE; Bonnefoy A; Boccon-Gibod I; Bouillet L; Picard M; Levesque G; Elfassy HL; Bachelard H; Hébert J; Bork K
Front Med (Lausanne); 2020; 7():358. PubMed ID: 32766265
[TBL] [Abstract][Full Text] [Related]
14. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
Henry Li H; Riedl M; Kashkin J
Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
[TBL] [Abstract][Full Text] [Related]
15. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
16. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Charest-Morin X; Hébert J; Rivard GÉ; Bonnefoy A; Wagner E; Marceau F
Front Immunol; 2018; 9():2183. PubMed ID: 30333824
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1.
Dobó J; Major B; Kékesi KA; Szabó I; Megyeri M; Hajela K; Juhász G; Závodszky P; Gál P
PLoS One; 2011; 6(5):e20036. PubMed ID: 21625439
[TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
Davis AE
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Modeling of Bradykinin-Mediated Angioedema States.
Marceau F; Bachelard H; Charest-Morin X; Hébert J; Rivard GE
Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32824891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]